Plaintiffs argue that companies like Novo Nordisk and Eli Lilly ignored clinical trial data, post-marketing surveillance, and adverse event reports that pointed to dangers such as stomach paralysis, intestinal obstruction, and permanent vision damage
Langworth S, Elinder C, Gthe C-J, Vesterber O (1991) Biological monitoring of environmental and occupational exposure to mercury
21 Comparative trials favor long acting agents (exenatide once weekly, liraglutide, dulaglutide, semaglutide) over short acting agents (exenatide twice daily and lixisenatide) in providing superior glycemic control
Magnesium and Fertility The often-overlooked mineral that underpins hundreds of metabolic reactions relevant to conception
Why am I not losing weight on Ozempic
Can functional mushrooms help energy on a GLP-1